戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 positive cultures included in the study (196 Gram-positive, 44 Gram-negative, 32 polymicrobial, and 2
2  class of bacterial noncoding RNAs common in Gram-positive anaerobes.
3                         Filifactor alocis, a Gram-positive anaerobic bacterium, is now a proposed dia
4 curvulamine, a dimeric member with promising Gram-positive and -negative antibiotic activity.
5 with yeast cells and various strains of both Gram-positive and -negative bacteria revealed distinct b
6 ll fibrous platform effectively inhibit both gram-positive and -negative bacteria without inducting o
7 nt antibiotic reservoir is effective against gram-positive and -negative bacteria.
8           All methods were evaluated on four Gram-positive and four Gram-negative bacterial species t
9 t anticancer activity, in addition to strong Gram-positive and Gram-negative antibiotic character.
10 e salt-functionalized filters quickly killed Gram-positive and Gram-negative bacteria aerosols in vit
11 ly, our data show that neutrophils recognize Gram-positive and Gram-negative bacteria by means of mul
12 esults show that DNA from various, unrelated gram-positive and gram-negative bacteria results in a mo
13 tivity exhibited by the extract against both Gram-positive and Gram-negative bacteria suggests the pr
14                            The proportion of Gram-positive and Gram-negative bacteria were 135(68.2%)
15 mmatory responses that distinguished between Gram-positive and Gram-negative bacteria, both in vitro
16 trum antibiotics, with efficacy against both gram-positive and gram-negative bacteria, has the potent
17 hibits the growth of different rainbow trout Gram-positive and Gram-negative bacteria, namely Lactoco
18 nnocua and E. coli ATCC25922, as examples of Gram-positive and Gram-negative bacteria, respectively,
19 ng antibacterial activity against the tested Gram-positive and Gram-negative bacteria, with a large z
20 urface and significant differences among the Gram-positive and Gram-negative bacteria.
21 d to be an important virulence trait in many gram-positive and gram-negative bacteria.
22 bel-free impedance sensor for discriminating Gram-positive and Gram-negative bacteria.
23 al structural motif of peptidoglycan of both Gram-positive and Gram-negative bacteria.
24 ectrum antibacterial properties against both Gram-positive and Gram-negative bacteria.
25 chanisms have been researched extensively in Gram-positive and Gram-negative bacteria.
26  affinity-based protein profiling (AfBPP) in Gram-positive and Gram-negative bacteria.
27 ave exhibited promising results against both Gram-positive and Gram-negative bacteria.
28 nosa and Staphylococcus aureus, representing Gram-positive and Gram-negative bacteria.
29 lycan (PGN) is a cell wall component of both Gram-positive and Gram-negative bacteria.
30 rs induce deformation and penetration of the Gram-positive and Gram-negative bacterial cell envelope,
31 lied to the analysis of intact proteins from Gram-positive and Gram-negative bacterial colonies sampl
32 11 displays antimicrobial activities against gram-positive and gram-negative bacterial pathogens, the
33 molecules, bacteriocins are produced by both gram-positive and gram-negative bacterial species and ar
34 hich is shown to be taken up in a variety of gram-positive and gram-negative bacterial strains in vit
35  pathogens, and antibiofilm activity against gram-positive and gram-negative biofilms.
36 trum sterilizing activity against a panel of gram-positive and gram-negative ESKAPE pathogens, and an
37 -deoxyglucosone (3-DG) were assessed against Gram-positive and Gram-negative pathogenic and food spoi
38 in reducing the intracellular burden of both Gram-positive and Gram-negative pathogenic bacteria.
39     Acute skin infections that involve mixed gram-positive and gram-negative pathogens must also be c
40 xacin is unique in being active against both gram-positive and gram-negative pathogens that cause ski
41                                   A panel of Gram-positive and Gram-negative pathogens used to evalua
42 ition, and the antibacterial activity across Gram-positive and Gram-negative pathogens with N-linked
43 xhibited excellent efficacy against selected Gram-positive and Gram-negative pathogens, as well as cl
44  can effectively label FtsZ in all the above Gram-positive and Gram-negative pathogens.
45 e an enhanced in vitro potency for resistant Gram-positive and Gram-negative pathogens.
46 ve bactericidal drugs and a diverse range of Gram-positive and Gram-negative species (Escherichia col
47 madacycline displays potent activity against gram-positive and many gram-negative bacteria, including
48 veral derivatives found to be active against Gram-positive and mycobacterial pathogens.
49 el area for antimicrobial discovery to fight Gram-positive and S. aureus infections.
50 were coagulase-negative staphylococci, other gram-positive, and gram-negative bacteria, respectively.
51 ts on a benzisoxazole scaffold with improved Gram-positive antibacterial activity relative to previou
52                                          The Gram-positive B. subtilis show a much higher conductivit
53 sease is a rare systemic disease caused by a gram-positive bacillus called Tropheryma whipplei.
54 he proposed EAST is successfully applied for Gram-positive Bacillus subtilis and Gram-negative Escher
55 r in both Gram-negative Escherichia coli and Gram-positive Bacillus subtilis.
56 : the Gram-negative Escherichia coli and the Gram-positive Bacillus subtilis.
57                   We test the system against Gram-positive (Bacillus subtilis) and Gram-negative (Esc
58  Gram-negative (Pseudomonas fluorescens) and Gram-positive (Bacillus thuringiensis) bacterial species
59 DnaD protein is essential in low G+C content gram positive bacteria and is involved in replication in
60 d in 70% of patients, with a predominance of Gram-positive bacteria (93%).
61 tive bacteria (n = 210) outnumbered those by Gram-positive bacteria (n = 142).
62                                      Most of Gram-positive bacteria anchor surface proteins to the pe
63 ignaling', exists in other Gram-negative and Gram-positive bacteria and displays species-specificity.
64 assays showed antimicrobial activity against Gram-positive bacteria and fission yeast.
65 on-classically secreted effector proteins in Gram-positive bacteria and further inspire the developme
66 ibiotic activity (MIC = 15.6 mug/mL) against Gram-positive bacteria and growth reduction of Gram-nega
67              Here, we characterized GPs from Gram-positive bacteria and heterokont algae acting on be
68  on the biogenesis and functions of EVs from Gram-positive bacteria and identify key areas for future
69  of gut microbiota with reduced abundance of gram-positive bacteria and increased abundance of gram-n
70 ancomycin, an antibiotic that acts mainly on gram-positive bacteria and is restricted to the gut, pot
71 ins are related to class IIa bacteriocins of Gram-positive bacteria and kill members of the Bacteroid
72 lecular patterns including peptidoglycans of Gram-positive bacteria and lipopolysaccharides of Gram-n
73 rium spp. have demonstrated EV production in Gram-positive bacteria and shown the great importance EV
74                      Because the features of Gram-positive bacteria are fundamentally different relat
75                            EVs purified from Gram-positive bacteria are implicated in virulence, toxi
76 he serine-rich repeat (SRR) glycoproteins of Gram-positive bacteria are large, cell wall-anchored adh
77                                              Gram-positive bacteria are prominent members of plant-as
78 A similar mechanism probably operates in the gram-positive bacteria as well, but these systems have b
79 nally, we discover aminoacyl-PGs not only in Gram-positive bacteria but also in Gram-negative C. jeju
80 none oxidoreductases (Sdh) are widespread in Gram-positive bacteria but little is known about the cat
81 bumin (ALA) and oleic acid and kills several Gram-positive bacteria by a mechanism that bears resembl
82                                              Gram-positive bacteria colonize mucosal tissues, withsta
83                         The cell envelope of Gram-positive bacteria generally comprises two types of
84                             The cell wall of Gram-positive bacteria has been shown to mediate environ
85 o differences in cell wall structure, EVs in Gram-positive bacteria have been disregarded for decades
86                                              Gram-positive bacteria have developed secretion systems
87              Nonetheless, Listeria and other Gram-positive bacteria have evolved an impressively dive
88 ndant in the smokers at baseline and so were Gram-positive bacteria in the non-smokers (P <0.01).
89  has been widely used to treat infections of Gram-positive bacteria including Clostridium difficile a
90             Horizontal gene transfer between Gram-positive bacteria leads to a rapid spread of virule
91 -1'-enyl, 2-acyl phospholipids) in anaerobic Gram-positive bacteria led to studies on the physical ch
92                                              Gram-positive bacteria like Bacillus and phytopathogen R
93 peptides when the flies were challenged with Gram-positive bacteria Micrococcus luteus In this settin
94 Pseudoalteromonas sp. strain CF6-2) can kill Gram-positive bacteria of diverse peptidoglycan (PG) che
95 enteen CRBSIs were recurrent; infection with gram-positive bacteria predicted recurrence.
96 ream biological effects of EVs released from gram-positive bacteria remain poorly characterized.
97                             Adhesive pili in Gram-positive bacteria represent a variety of extracellu
98  for half a century but the possibility that Gram-positive bacteria secrete extracellular vesicles (E
99                  Here we extend our study to Gram-positive bacteria showing that coupling game-theory
100                           We have found that Gram-positive bacteria Staphylococcus aureus and Enteroc
101  found to specifically inhibit the growth of Gram-positive bacteria Staphylococcus aureus with MIC(50
102 acetic acid) inhibited all Gram-negative and Gram-positive bacteria tested.
103 ghput scRNA-seq method for Gram-negative and Gram-positive bacteria that can resolve heterogeneous tr
104 treptogramins(2), potent antibiotics against Gram-positive bacteria that inhibit the bacterial riboso
105 tein export systems in mycobacteria and many Gram-positive bacteria that mediate a broad range of fun
106 SCH-79797, that kills both Gram-negative and Gram-positive bacteria through a unique dual-targeting m
107 vation (up to 95%) against Gram-negative and Gram-positive bacteria was observed when curcumin-functi
108 tions in this study were caused by bacteria; Gram-positive bacteria were responsible for most cases.
109 en between structurally similar molecules in gram-positive bacteria while also demonstrating the powe
110 nductance and renders it ineffective against Gram-positive bacteria while nevertheless enhancing its
111 gle-cell transcriptomes of Gram-negative and Gram-positive bacteria with high purity and low bias, wi
112 e bacteria and lipoteichoic acids (LTA) from Gram-positive bacteria with host lipoprotein carriers in
113 ncubated with agonists of TLR2 (receptor for gram-positive bacteria), TLR4 (receptor for gram-negativ
114 gulase-negative staphylococci not included): Gram-positive bacteria, 58%; Gram-negative bacteria, 78%
115                                           In Gram-positive bacteria, a subset of surface proteins rel
116 isteria monocytogenes, as well as many other Gram-positive bacteria, and which highlights a more gene
117 a potent antibiotic against a broad range of Gram-positive bacteria, but its medical applications hav
118 nel to other methods of identification of 20 Gram-positive bacteria, four antimicrobial resistance ge
119 nd has broad-spectrum activity that includes gram-positive bacteria, gram-negative bacteria, anaerobe
120  cultures in patients with Gram-negative and Gram-positive bacteria, including 8/60 (13.3%) patients
121                                              Gram-positive bacteria, including major clinical pathoge
122 robial agent; it performed well against many Gram-positive bacteria, including multidrug resistant st
123                  It has been found mainly in Gram-positive bacteria, including pathogenic bacteria li
124 hat rTCP96 aggregates both Gram-negative and Gram-positive bacteria, including Staphylococcus aureus
125 y used antibiotics against gram-negative and gram-positive bacteria, including Staphylococcus aureus,
126 loped to overcome the acquired resistance in Gram-positive bacteria, intrinsic resistance in Gram-neg
127  that modulates QS in both Gram-negative and Gram-positive bacteria, is phosphorylated by LsrK, and t
128                  The O-acetylating enzyme in Gram-positive bacteria, O-acetyltransferase A (OatA), is
129 s no cross-reactivity with other mollicutes, Gram-positive bacteria, or Gram-negative bacteria.
130                                           In Gram-positive bacteria, peptidoglycan is tens of nanomet
131                                        Among Gram-positive bacteria, Staphylococcus aureus were predo
132 ed molecular pattern (PAMP) of extracellular gram-positive bacteria, via ester hydrolysis.
133  resistance seems to be universal across the Gram-positive bacteria, while the type of coselected tra
134 igenetic regulation of cellular functions in Gram-positive bacteria.
135 he virulence of numerous medically important Gram-positive bacteria.
136  determinants dispersed and maintained among Gram-positive bacteria.
137  fatty acid and phospholipid biosynthesis in Gram-positive bacteria.
138 stance determinants and adaptations in other Gram-positive bacteria.
139 r background for cultures with non-S. aureus Gram-positive bacteria.
140 ntimicrobial or quorum signaling peptides in Gram-positive bacteria.
141 EVs have now been described for a variety of Gram-positive bacteria.
142  interaction with the peptidoglycan layer of Gram-positive bacteria.
143 ues are late cell division proteins found in Gram-positive bacteria.
144  differentiate between viable and non-viable Gram-positive bacteria.
145 y and potency against both Gram-negative and Gram-positive bacteria.
146 th P. aeruginosa and other gram-negative and gram-positive bacteria.
147 nterococcus faecalis as a model organism for Gram-positive bacteria.
148 e Au(I) complexes for both Gram-negative and Gram-positive bacteria.
149 f complex rhamnose-containing CWPSs in other Gram-positive bacteria.
150 hibitory concentration (MIC) values] against Gram-positive bacteria.
151 gulates the biosynthesis of phospholipids in Gram-positive bacteria.
152 e pathway that produces phosphatidic acid in Gram-positive bacteria.
153 mids carrying antibiotic resistance genes in Gram-positive bacteria.
154 used by staphylococci, enterococci and other Gram-positive bacteria.
155 Pseudoalterin binds to the glycan strands of Gram positive bacterial PG and degrades the PG peptide c
156                  TEM imaging revealed intact gram-positive bacterial and fungal cells whereas the gra
157 robial lipids and restricted commensalism of Gram-positive bacterial communities.
158 ort for the treatment of multidrug-resistant Gram-positive bacterial infections.
159                                 It is also a Gram-positive bacterial model to study phage-host intera
160      Superantigens (SAgs) released by common Gram-positive bacterial pathogens have been reported to
161 r the synthesis of membrane phospholipids in Gram-positive bacterial pathogens.
162 a and shown the great importance EVs have in Gram-positive bacterial physiology and disease progressi
163  RgNanOx homologues across Gram-negative and Gram-positive bacterial species and co-occurrence with s
164 n fluorescence measurements on two different gram-positive bacterial species as the cells uptake memb
165 The model represents the first ME-model of a Gram-positive bacterium and captures all major central m
166 pp, all directly interact with XPRT from the Gram-positive bacterium Bacillus subtilis and inhibit XP
167                                          The gram-positive bacterium Bacillus subtilis has become a m
168                                          The Gram-positive bacterium Bacillus subtilis uses serine no
169 stable antimicrobial peptide secreted by the Gram-positive bacterium Bacillus subtilis.
170 of an exclusion mechanism in ICEBs1 from the Gram-positive bacterium Bacillus subtilis.
171 ibe the characterization of a MINPP from the Gram-positive bacterium Bifidobacterium longum (BlMINPP)
172 ects survival to infection by the pathogenic Gram-positive bacterium Micrococcus luteus.
173           The dextransucrase DSR-OK from the Gram-positive bacterium Oenococcus kitaharae DSM17330 pr
174 acterial GH161 gene sequence (PapP) from the Gram-positive bacterium Paenibacillus polymyxa ATCC 842
175                   Staphylococcus aureus is a Gram-positive bacterium responsible for a number of dise
176       Bacillus anthracis is a spore-forming, Gram-positive bacterium responsible for anthrax, an acut
177          The fungus Candida albicans and the Gram-positive bacterium S. aureus can form polymicrobial
178 tance in the preeminent etiologic agent, the Gram-positive bacterium Staphylococcus aureus Bacterial
179                                          The Gram-positive bacterium Staphylococcus aureus produces v
180                                          The gram-positive bacterium Staphylococcus aureus secretes a
181                   Staphylococcus aureus is a Gram-positive bacterium that can cause both superficial
182                  Listeria monocytogenes is a Gram-positive bacterium that causes listeriosis.
183                   Clostridium difficile is a Gram-positive bacterium with an S-layer covering its pep
184 tablishment of a medial division site in the Gram-positive bacterium, Bacillus subtilis.
185 o damage caused by Listeria monocytogenes, a Gram-positive bacterium, BCV rupture by Gram-negative pa
186          Bacillus anthracis, a spore-forming gram-positive bacterium, causes anthrax.
187                                          The Gram-positive bacterium, Staphylococcus aureus, is a ver
188 enMark Dx ePlex Blood Culture Identification Gram-Positive (BCID-GP) Panel is a multiplex nucleic aci
189 lammatory response between Gram-negative and Gram-positive BK and to determine the diagnostic value o
190  RDT facilitated antibiotic optimization for Gram-positive BSIs but led to unnecessary escalation of
191 iated with early deescalation of therapy for Gram-positive BSIs.
192                                          The Gram-positive cell wall consists of peptidoglycan functi
193 ccounting for the physical properties of the Gram-positive cell wall, was developed.
194 investigate and improve understanding of the Gram-positive cellular microenvironment.
195 terial colonies (including Gram-negative and Gram-positive clinical isolates) grown on agar media by
196  than vancomycin against multidrug-resistant Gram-positive clinical isolates, including vancomycin- a
197 e separated states into bacteremia caused by Gram-positive cocci (GPC), susceptible Gram-negative bac
198                As ComW seems to be unique to Gram-positive cocci and has no sequence similarity with
199 ved study therapy, excluding those with only gram-positive cocci at baseline).
200                      The primary outcome was gram-positive cocci, skin-flora-related, or central-line
201 e separated states into bacteremia caused by gram-positive cocci, susceptible gram-negative bacilli (
202                      The primary outcome was gram-positive cocci-related, skin flora-related, or cent
203 e a highly effective approach for preventing gram-positive cocci-related, skin flora-related, or cent
204 ld be a highly effective approach to prevent gram-positive-cocci-, skin-flora-related, or central-lin
205                   Enterococcus faecalis is a Gram-positive commensal bacterium native to the gastroin
206                                              Gram-positive coverage remained unchanged in the A22-alk
207                             In contrast, for Gram-positive cultures, the VG results correlated with a
208 Gram-negative Escherichia coli (E. coli) and Gram-positive Enterococcus durans (E. durans) and Staphy
209 at-killed Gram-negative Escherichia coli and Gram-positive Enterococcus faecalis applied during the f
210 ed Gram-negative Escherichia coli Symbio and Gram-positive Enterococcus faecalis Symbio or placebo fr
211 ive uropathogenic Escherichia coli (UPEC) or Gram-positive Enterococcus faecalis, we used a mouse tra
212                 A protocol was developed for Gram-positive (Enterococcus faecalis) and Gram-negative
213 embraned cells and the derived nature of the Gram-positive envelope following multiple OM losses.
214 matory cytokine IL-17 after stimulation with gram-positive exotoxins.
215                   During aerobic growth, the Gram-positive facultative anaerobe and opportunistic hum
216 teria have one pathway or the other, but the Gram-positive, facultative intracellular pathogen Lister
217 antibiotics that selectively suppress mainly gram-positive (fidaxomicin, streptomycin) or gram-negati
218 (WD) is a rare, chronic, infection caused by gram-positive filamentous aerobic actinobacterium Trophe
219                                         Many Gram-positive Firmicutes also have N-acylated lipoprotei
220 s largely due to an increase in abundance of Gram-positive Firmicutes and a concurrent decrease in Gr
221 d TNF-alpha proteins, gram-negative (GN) and gram-positive (GP) bacterial DNA, and the antibiotic-res
222  Virulent strains of Streptococcus pyogenes (gram-positive group A Streptococcus pyogenes [GAS]) recr
223 e virulent bacteria (gram-negative and other gram-positive groups) and presentation with light percep
224 reptococcus pneumoniae (Spn) is an important Gram-positive human pathogen that causes millions of inf
225 catechol species are important Fe sources in Gram-positive human pathogens, since PiuA functions in t
226 osporin with broad in vitro activity against gram-positive (including methicillin-resistant Staphyloc
227 tructure infections (ABSSSI), including both gram-positive (including methicillin-resistant Staphyloc
228 ase hepcidin in response to Gram-negative or Gram-positive infection.
229 vancomycin is a mainstay in the treatment of Gram-positive infection.
230 gainst clinically relevant Gram-negative and Gram-positive infections via enhanced leukocyte recruitm
231  a key agent for treatment of drug-resistant Gram-positive infections.
232                  Listeria monocytogenes is a Gram-positive, intracellular pathogen harboring the surf
233 ed, antibiotic resistance was more common in gram-positive isolates.
234 tations, we show that encapsulating LsLAI in gram-positive Lactobacillus plantarum that is chemically
235 uated using osmotic stress management in the Gram-positive model bacterium Bacillus subtilis as proof
236 at RNAPs outpace pioneering ribosomes in the Gram-positive model bacterium Bacillus subtilis, and tha
237                                       In the Gram-positive model bacterium, Bacillus subtilis, the fi
238                                       In the gram-positive model of shock mediated by toxic shock syn
239 hat spans the mycolic acid outer membrane of Gram-positive mycolate, Corynebacterium jeikeium.
240              Sequence alignments reveal that Gram-positive NanK enzymes belong to the Repressor, ORF,
241 K), which is the first characterization of a Gram-positive NanK.
242 tion of the gastrointestinal tract with this Gram-positive, obligate anaerobe can lead to potentially
243                      Streptococcus mutans, a Gram-positive odontopathogen that contributes to the ena
244 Ryway was utilized to re-design Debio-1452-a Gram-positive-only antibiotic(8)-into versions that accu
245 nd a general blueprint for the conversion of Gram-positive-only compounds into broad-spectrum antibio
246                   Staphylococcus aureus is a Gram-positive opportunistic pathogen that causes a varie
247 llateral effects in Enterococcus faecalis, a gram-positive opportunistic pathogen.
248 ot have clinically relevant activity against Gram-positive or anaerobic organisms.
249 arative method to Gram stain for delineating gram-positive or gram-negative bacteria or fungi within
250 on between cell envelopes with one membrane (Gram-positive or monoderm) and those with two membranes
251                   Enterococcus faecalis is a gram-positive organism responsible for serious infection
252 o lose efficacy over time was gentamicin for gram-positive organisms (P = .005).
253 ns in the PCT arm for patients infected with gram-positive organisms or Escherichia coli and signific
254                                              Gram-positive organisms predominated (48%), followed by
255 sis, a common cell wall polysaccharide among Gram-positive organisms.
256 sses a second mechanism of action that kills gram-positive organisms.
257 g toxin, hemolysin BL (HBL), produced by the gram-positive pathogen Bacillus cereus.
258 otein as a novel PASTA-eSTK substrate in the Gram-positive pathogen Listeria monocytogenes.
259  key role in penicillin-induced lysis of the Gram-positive pathogen Streptococcus pneumoniae (Sp).
260 ), displayed potent activity against several Gram-positive pathogenic bacteria.
261                Clostridioides difficile is a Gram-positive, pathogenic bacterium and a prominent caus
262 lecular methods for the identification of 20 Gram-positive pathogens and four antimicrobial resistanc
263 es inhibit the growth of multidrug-resistant Gram-positive pathogens by disrupting cell wall biosynth
264 eate antibody-mediated uptake and killing of Gram-positive pathogens remain extremely limited.
265 e that BOFP binds the FtsZ proteins from the Gram-positive pathogens Staphylococcus aureus, Enterococ
266                        Unlike those in other Gram-positive pathogens such as Staphylococcus aureus an
267 he WalR-WalK pathway is conserved among many Gram-positive pathogens where it controls transcription
268         This modification occurs in numerous Gram-positive pathogens, including methicillin-resistant
269    While horine was potent primarily against gram-positive pathogens, verine showed broad-spectrum an
270 n resistance methyltransferase found in many Gram-positive pathogens, whereas ErmE is found in the so
271 therapeutic strategies against GAS and other Gram-positive pathogens.
272 owth phase-induced lysis for other important Gram-positive pathogens.
273 n elucidated for peptide-based QS systems in gram-positive pathogens.
274 the design of new antimicrobial agents among Gram-positive pathogens.
275 ibits enhanced potency, particularly against gram-positive pathogens.
276 cuss recent advances in our understanding of Gram-positive, plant-associated bacteria and provide a f
277                   Abiotrophia defectiva is a Gram-positive pleomorphic bacterium, commonly found in t
278  its human homolog MRGPRX2 are receptors for Gram-positive QSMs, including competence-stimulating pep
279 nts, initial staining of liquid media showed Gram-positive rods or cocci, including some cocci in cha
280  treatments have the ability to inhibit both gram-positive (S. aureus) and gram-negative (E. coli) ba
281 on between influenza virus on the surface of Gram-positive, S. pneumoniae and S. aureus, and Gram-neg
282 ommonly used clinically for the treatment of Gram-positive skin and skin structure infections (SSSI),
283  of IL-10, whereas inflammatory responses to Gram-positive species were more sustained due to the abs
284 uginosa, and between 0.03 and 1 mg/L for MDR Gram-positive species.
285 -free readout on unlabeled Gram-negative and Gram-positive species.
286 ioides (formerly Clostridium) difficile is a Gram-positive, spore-forming anaerobe and a leading caus
287                  Geobacillus sp. WSUCF1 is a Gram-positive, spore-forming, aerobic and thermophilic b
288                Clostridioides difficile is a Gram-positive, spore-forming, anaerobic bacterium that i
289                Clostridioides difficile is a Gram-positive, spore-forming, toxin-producing anaerobe p
290         We quantified doubling times of both Gram positive ( Staphylococcus aureus, Enterococcus faec
291  vitro infection model with heat-inactivated Gram-positive (Staphylococcus aureus) and Gram-negative
292                                 Among the 77 gram-positive strains tested, 76 (98.7%) were vancomycin
293 obial activity, with higher efficacy against Gram-positive strains than Gram-negative ones.
294 the outer cell wall of Lactococcus lactis, a Gram-positive surrogate that otherwise lacks adhesins to
295                               For pathogenic Gram-positive targets (Bacillus cereus group, Enterococc
296 obal biochemical and structural picture of a Gram-positive Tfp and have fundamental implications for
297                               Strains of the Gram-positive, thermophilic bacterium Geobacillus stearo
298 -17-mediated pathology in situations such as gram-positive toxic shock or Mycobacterium infection.
299 ctivity against both sensitive and resistant Gram positive (using 1500 ppm) as well as sensitive and
300 vity extends to a range of Gram-negative and Gram-positive wound pathogens in planktonic culture and,

 
Page Top